Data from Oncomine (https://www.oncomine.org/) demonstrated that BAX was expressed at low levels, while BCL2 was expressed at high levels in breast cancer tumors compared to normal tissues (Figures 7C, S3). The gene discussed is BCL2; the disease is breast carcinoma.